ESCO Technologies Reports Adjusted EPS of $2.67 and Quarterly Sales of $384 Million
Key Facts
ESCO Technologies reported results on November 19, 2026, for the fourth quarter and fiscal year ended September 30, posting adjusted earnings from continuing operations of $2.67 per share for the quarter, up 15% from $2.32 a year earlier. GAAP earnings per share from continuing operations were $1.97, compared with $1.73 in the fourth quarter of 2025, an increase of 14%. The distinction puts adjusted earnings alongside GAAP earnings per share and specifies the year-over-year comparison for each. The company also reported quarterly sales of $384 million, versus $353 million in the comparable period, up 9%. ESCO said fourth-quarter sales growth was entirely organic.
Business growth also extended to new orders booked during the quarter, which rose 22% to $392 million, an increase of $71 million from the comparable period. The book-to-bill ratio was 1.02 times, meaning the value of orders received during the period slightly exceeded sales recorded. These figures provide a parallel view of quarterly revenue results: organic sales increased, while new orders grew at a faster pace. For fiscal 2026, the company said new orders rose 11% to $1.7 billion, an increase of $172 million. This helped lift the year-end backlog to a record $1.5 billion.
By segment, aerospace and defense led the increase in quarterly sales, which rose 12% to $190.2 million from $170.4 million in the fourth quarter of 2025. The company attributed the segment's growth during the quarter to strong demand in naval and commercial aerospace markets. In the broader annual picture, ESCO said fiscal-year sales growth was driven by strong demand in naval, commercial aerospace and military markets. These stated factors link performance to activity in specific segments, although the company did not detail in this statement how much each contributed to annual growth. The quarterly results came in a year in which the company recorded higher annual sales and adjusted earnings per share from continuing operations.
ESCO's fiscal 2026 sales were about $1.3 billion, up 21% from the prior year, while adjusted earnings per share from continuing operations rose 40% to $8.42. Cash flow from continuing operating activities was $102 million in the fourth quarter and totaled $296 million for the fiscal year. Annual cash flow was $95 million higher than in fiscal 2025. These figures add annual measures of revenue, earnings and cash flow to the picture of a record backlog. Chief Executive Brian Saylor said the addition of Megger, the record backlog and the company's strong positions in markets with long-term growth drivers “reinforce our confidence in the future of ESCO.”
For fiscal 2027, the company said it is targeting sales growth of 55% to 58%, to a range of $2.05 billion to $2.09 billion, with adjusted earnings per share of $9.40 to $9.70. It said the Megger deal will add $640 million to $660 million in revenue in 2027, and that it expects to achieve $20 million in integration savings next year. The company also forecast first-quarter fiscal 2027 adjusted earnings per share of $1.85 to $1.95, with expected year-over-year growth of 13% to 19% compared with the first quarter of 2026. The guidance incorporates the deal's contribution into annual sales expectations, alongside the company's estimates for earnings and integration savings. In trading on November 19, the stock closed at $223.02 after falling 2.42% during the regular session, then rose 5.37% to $235 in extended trading.